Acute Pyogenic Meningitis: Evidence‑Based Treatment Recommendations

Empiric Antimicrobial Therapy

• Start vancomycin plus a third‑generation cephalosporin (ceftriaxone or cefotaxime) immediately in all suspected cases (adults and children). This combination is recommended to cover resistant Streptococcus pneumoniae and other common pathogens. 1
• Vancomycin must never be used as monotherapy; it should always be paired with a third‑generation cephalosporin. 1
• Target a vancomycin trough concentration of roughly 15–20 mg/L during therapy to ensure adequate serum levels. 1
• If dexamethasone is planned for suspected pneumococcal meningitis, add rifampin to the vancomycin‑plus‑cephalosporin regimen because dexamethasone can diminish vancomycin penetration into the cerebrospinal fluid. 1
• Administer the first antibiotic dose as soon as bacterial meningitis is suspected, after obtaining blood cultures, without waiting for imaging or lumbar puncture. Delays increase mortality and neurologic injury. 2
• Early antibiotic delivery (before the Glasgow Coma Scale falls below 10) markedly lowers mortality and improves neurologic outcomes. 2

Adjunctive Dexamethasone

• Give dexamethasone 10 mg IV every 6 hours for 4 days (total 40 mg/day) in adults when bacterial meningitis is suspected. 1
• In children, use dexamethasone 0.15 mg/kg IV every 6 hours for 2–4 days (duration tailored to the pathogen). 2
• Administer dexamethasone 10–20 minutes before, or simultaneously with, the first antibiotic dose to blunt the inflammatory cascade triggered by bacterial lysis. 1
• For adult pneumococcal meningitis, dexamethasone reduces unfavorable outcomes from 52 % to 26 % and mortality from 34 % to 14 % (strong evidence). 1
• In the broader adult bacterial meningitis population, dexamethasone lowers unfavorable outcomes from 25 % to 15 % and mortality from 15 % to 7 % (strong evidence). 1
• The greatest benefit is observed in patients with moderate‑to‑severe disease (Glasgow Coma Scale ≤ 13). 1

Critical Care Management

Indications for Immediate ICU Transfer

• Rapidly evolving rash, Glasgow Coma Scale ≤ 12 or a drop > 2 points, cardiovascular instability or severe sepsis, uncontrolled seizures, respiratory compromise/hypoxia, or evidence of limb ischemia warrant prompt transfer to an intensive‑care setting. 3

Hemodynamic Management

• Maintain euvolemia using isotonic crystalloids as the initial fluid of choice. 3
• Target a mean arterial pressure ≥ 65 mmHg, adjusting for age and the presence of cerebral edema. 3
• Use norepinephrine as the first‑line vasopressor after euvolemia is achieved. 3
• Consider albumin infusion for persistent hypotensive shock despite adequate fluid resuscitation. 3
• Add hydrocortisone 200 mg daily for refractory hypotensive shock. 3

Intracranial Pressure (ICP) Management

• Apply basic measures (head elevation, sedation, analgesia) to control suspected or proven raised ICP and to preserve cerebral perfusion pressure. 3
• Intubate promptly when the Glasgow Coma Scale falls below 12 to protect the airway and facilitate ventilation. 3
• Do not restrict fluids in an attempt to lower cerebral edema; fluid restriction is not recommended. 3
• Routine invasive ICP monitoring is not advised in routine bacterial meningitis care. 3

Interventions to Avoid

• Avoid glycerol therapy; trials in Malawi showed increased adult mortality and no benefit in children. 3
• Avoid induced therapeutic hypothermia; a randomized trial was halted early because of excess mortality. 3

Monitoring and Pitfalls

• When dexamethasone is used for pneumococcal meningitis, monitor closely for adverse outcomes, especially in infections caused by highly penicillin‑ and cephalosporin‑resistant strains. 1
• Treat any seizures early and employ EEG monitoring for patients with fluctuating consciousness or subtle abnormal movements to detect non‑convulsive status epilepticus. 3

Resolution of Meningeal Irritation After Antibiotic Therapy

Timeline of Clinical Improvement

• Fever typically resolves within 24–48 hours after initiating appropriate antibiotics and is used as a key criterion for clinical stability. 4, 5
• Most serious complications occur within the first 2–3 days of treatment; after this period they become exceedingly rare. 4, 5
• By days 5–6, patients should demonstrate clinical stability sufficient to consider transition from inpatient to outpatient therapy. 4, 5, 6
• Guidelines require absence of fever for at least 24–48 hours (without antipyretics) and evidence of clinical stability or improvement before discharge. 4, 5
• A minimum of 6 days of inpatient antimicrobial therapy is recommended before outpatient management can be contemplated. 4, 5, 7

Pathogen‑Specific Treatment Duration

• For meningococcal meningitis, antibiotics may be discontinued after 5 days if the patient has recovered. 6
• For pneumococcal meningitis, antibiotics may be discontinued after 10 days if the patient has recovered; the longer course reflects a more severe inflammatory response and need for prolonged therapy. 6, 4, 5

Criteria Indicating Adequate Response

• No fever for 24–48 hours without antipyretics. 4, 5, 7
• No significant neurologic dysfunction, focal findings, or seizure activity. 4, 5
• Clinical stability or improving condition with normalization of mental status. 4, 5, 7
• Ability to take fluids orally and maintain adequate intake. 4, 5

Warning Signs of Inadequate Response

• Persistence of meningeal signs beyond 48–72 hours suggests possible inadequate antibiotic penetration or infection with a resistant organism. 6
• Development of complications such as subdural empyema, brain abscess, or ventriculitis warrants further evaluation. 4
• Repeat lumbar puncture to assess CSF sterilization is recommended, especially for resistant pneumococcal strains. 6

Age‑Related Considerations

• Infants and young children may exhibit less specific features and a slower resolution of irritability and poor feeding compared with classic meningeal signs. 8, 9
• Headache and photophobia can persist for days to weeks after bacterial eradication, representing residual inflammation rather than treatment failure. 8, 9
• Neck stiffness often resolves more slowly than fever and may persist several days after other signs improve. 8, 9

Monitoring Strategy

• Critical period (first 48–72 hours): Close monitoring in an intensive‑care setting for patients with a Glasgow Coma Scale ≤12, rapidly evolving rash, or cardiovascular instability. 7
• Repeat lumbar puncture at 48–72 hours should be considered for penicillin/cephalosporin‑resistant pneumococcal infection. 6
• Stabilization period (days 3–6): Assess clinical stability criteria to determine suitability for outpatient therapy and ensure fever has been absent for 24–48 hours before discharge. 4, 5, 7
• Beyond day 6: Continue antibiotics for the pathogen‑specific duration even if symptoms have resolved to prevent relapse. 4, 5, 6